REFERENCES

Brault, A.C., A.M. Powers, G. Medina, E. Wang, W. Kang, R.A. Salas, J. De Siger, and S.G. Weaver. 2001. Potential sources of the 1995 Venezuelan equine encephalitis subtype IC epidemic. J. Virol. 75(13):5823-5832.

CDC (Centers for Disease Control and Prevention). 2004. Secondary and tertiary transfer of vaccinia virus among U.S. military personnel—United States and worldwide. MMWR Morb. Mortal. Wkly. Rep. 53:103-105.

CDC (Centers for Disease Control and Prevention). 2007. Household transmission of vaccinia virus from contact with a military smallpox vaccinee—Illinois and Indiana. MMWR Morb. Mortal. Wkly. Rep. 56:478-481.

CDC (Centers for Disease Control and Prevention). 2009. Laboratory-acquired vaccinia virus infection – Virginia, 2008. MMWR 58(29):797-800.

CDC/NIH (Centers for Disease Control and Prevention and National Institutes of Health). 2009. Biosafety in Microbiological and Biomedical Laboratories, 5th Ed. HHS Publication No. (CDC)21-1112. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institutes of Health [online]. Available: http://www.cdc.gov/biosafety/publications/bmbl5/BMBL.pdf [accessed Apr. 8, 2011].

Enserink, M., and L. Du. 2004. SARS. China dumps CDC head, probes lab. Science 305(5681):163.

EPA (U.S. Environmental Protection Agency). 2003. Framework for Cumulative Risk Assessment. EPA/630/P-02/001F. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, DC.

EPA (U.S. Environmental Protection Agency). 2004. Risk Assessment and Modeling-Air Toxics Risk Assessment Library, Vol.1. Technical Resources Manual. EPA-453-K-04-001A. Office of Air Quality Planning and Standards, U.S. Environmental Protection Agency, Research Triangle Park, NC [online]. Available: http://www.epa.gov/ttn/fera/risk_atra_vol1.html [accessed Apr. 8, 2011].

Friebel, C., and H. Steckel. 2010. Single-use disposable dry powder inhalers for pulmonary drug delivery. Expert Opin. Drug Deliv. 7(12) :1359-1372.

Haas, C.N., J.B. Rose, and C.P. Gerba. 1999. Quantitative Microbial Risk Assessment. New York: Wiley.

Hawkes, N. 1979. Small pox death in Britain challenges presumption of laboratory safety. Science 203(4383):855-856.

Hughes, C.M., D. Blythe, Y. Li, R. Reddy, C. Jordan, C. Edwards, C. Adams, H. Conners, C. Rasa, S. Wilby, J. Russell, K.S. Russo, P. Somsel, D.L. Wiedbrauk, C. Dougherty, C. Allen, M. Frace, G. Emerson, V.A. Olson, S.K. Smith, Z. Braden, J. Abel, W. Davidson, M. Reynolds, and I.K. Damon. 2001. Vaccinia virus infections in martial arts gym, Maryland, USA, 2008. Emerg. Infect. Dis. 17(4):730-733.

IOM (Institute of Medicine). 2006. Globalization, Biosecurity, and the Future of the Life Sciences. Washington, DC: The National Academies Press.

Ishikawa, F., M. Murano, M. Hiraishi, T. Yamaguchi, I. Tamai, and A. Tsuji. 2002. Insoluble powder formulation as an effective nasal drug delivery system. Pharm. Res. 19(8):1097-1104.

Kumamoto, H., and E.J. Henley. 1996. Probabilistic Risk Assessment and Management for Engineers and Scientists, 2nd Ed. New York, NY: Institute of Electrical and Electronics Engineers, Inc.

Lemonick, M.D., and A. Park. 1994. A deadly virus escapes. Time, September 5, 1994 [online]. Available: http://www.time.com/time/magazine/article/0,9171,981359,00.html [accessed Mar. 21, 2011].

Ludwig, G. 2011. Medical Countermeasure Test & Evaluation Facility. (U.S. Army Medical Research Institute for Infectious Diseases [USAMRIID] Recapitalization Project: Phase 2). Presentation at the First Meeting on the Review of Risk Assessment Approaches for the Medical Countermeasures Test & Evaluation Facility at Fort Detrick, Maryland, March 21, 2011, Frederick, MD.

Murray, C.J., and A.D. Lopez. 1994. Quantifying disability: Data, methods and results. Bull. World Health Organ. 72(3):481-494.

NRC (National Research Council). 1983. Risk Assessment in the Federal Government: Managing the Process. Washington, DC: National Academy Press.

NRC (National Research Council). 1994. Science and Judgment in Risk Assessment. Washington, DC: National Academy Press.

NRC (National Research Council). 2007. Technical Input on the National Institutes of Health’s Draft Supplementary Risk Assessments and Site Suitability Analyses for the National Emerging Infectious Diseases Laboratory, Boston University: A Letter Report. Washington, DC: The National Academies Press.

NRC (National Research Council). 2008. Technical Input on Any Additional Studies to Assess Risk Associated with Operation of the National Emerging Infectious Diseases Laboratory, Boston University: A Letter Report. Washington, DC: The National Academies Press.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 10
REFERENCES Brault, A.C., A.M. Powers, G. Medina, E. Wang, W. Kang, R.A. Salas, J. De Siger, and S.G. Weaver. 2001. Potential sources of the 1995 Venezuelan equine encephalitis subtype IC epidemic. J. Virol. 75(13):5823- 5832. CDC (Centers for Disease Control and Prevention). 2004. Secondary and tertiary transfer of vaccinia virus among U.S. military personnel—United States and worldwide. MMWR Morb. Mortal. Wkly. Rep. 53:103-105. CDC (Centers for Disease Control and Prevention). 2007. Household transmission of vaccinia virus from contact with a military smallpox vaccinee—Illinois and Indiana. MMWR Morb. Mortal. Wkly. Rep. 56:478-481. CDC (Centers for Disease Control and Prevention). 2009. Laboratory-acquired vaccinia virus infection – Virginia, 2008. MMWR 58(29):797-800. CDC/NIH (Centers for Disease Control and Prevention and National Institutes of Health). 2009. Biosafety in Microbiological and Biomedical Laboratories, 5th Ed. HHS Publication No. (CDC)21-1112. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institutes of Health [online]. Available: http://www.cdc.gov/biosafety/publications/bmbl5/BMBL.pdf [accessed Apr. 8, 2011]. Enserink, M., and L. Du. 2004. SARS. China dumps CDC head, probes lab. Science 305(5681):163. EPA (U.S. Environmental Protection Agency). 2003. Framework for Cumulative Risk Assessment. EPA/630/P- 02/001F. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, DC. EPA (U.S. Environmental Protection Agency). 2004. Risk Assessment and Modeling-Air Toxics Risk Assessment Library, Vol.1. Technical Resources Manual. EPA-453-K-04-001A. Office of Air Quality Planning and Standards, U.S. Environmental Protection Agency, Research Triangle Park, NC [online]. Available: http://www.epa.gov/ttn/fera/risk_atra_vol1.html [accessed Apr. 8, 2011]. Friebel, C., and H. Steckel. 2010. Single-use disposable dry powder inhalers for pulmonary drug delivery. Expert Opin. Drug Deliv. 7(12) :1359-1372. Haas, C.N., J.B. Rose, and C.P. Gerba. 1999. Quantitative Microbial Risk Assessment. New York: Wiley. Hawkes, N. 1979. Small pox death in Britain challenges presumption of laboratory safety. Science 203(4383):855- 856. Hughes, C.M., D. Blythe, Y. Li, R. Reddy, C. Jordan, C. Edwards, C. Adams, H. Conners, C. Rasa, S. Wilby, J. Russell, K.S. Russo, P. Somsel, D.L. Wiedbrauk, C. Dougherty, C. Allen, M. Frace, G. Emerson, V.A. Olson, S.K. Smith, Z. Braden, J. Abel, W. Davidson, M. Reynolds, and I.K. Damon. 2001. Vaccinia virus infections in martial arts gym, Maryland, USA, 2008. Emerg. Infect. Dis. 17(4):730-733. IOM (Institute of Medicine). 2006. Globalization, Biosecurity, and the Future of the Life Sciences. Washington, DC: The National Academies Press. Ishikawa, F., M. Murano, M. Hiraishi, T. Yamaguchi, I. Tamai, and A. Tsuji. 2002. Insoluble powder formulation as an effective nasal drug delivery system. Pharm. Res. 19(8):1097-1104. Kumamoto, H., and E.J. Henley. 1996. Probabilistic Risk Assessment and Management for Engineers and Scientists, 2nd Ed. New York, NY: Institute of Electrical and Electronics Engineers, Inc. Lemonick, M.D., and A. Park. 1994. A deadly virus escapes. Time, September 5, 1994 [online]. Available: http://www.time.com/time/magazine/article/0,9171,981359,00.html [accessed Mar. 21, 2011]. Ludwig, G. 2011. Medical Countermeasure Test & Evaluation Facility. (U.S. Army Medical Research Institute for Infectious Diseases [USAMRIID] Recapitalization Project: Phase 2). Presentation at the First Meeting on the Review of Risk Assessment Approaches for the Medical Countermeasures Test & Evaluation Facility at Fort Detrick, Maryland, March 21, 2011, Frederick, MD. Murray, C.J., and A.D. Lopez. 1994. Quantifying disability: Data, methods and results. Bull. World Health Organ. 72(3):481-494. NRC (National Research Council). 1983. Risk Assessment in the Federal Government: Managing the Process. Washington, DC: National Academy Press. NRC (National Research Council). 1994. Science and Judgment in Risk Assessment. Washington, DC: National Academy Press. NRC (National Research Council). 2007. Technical Input on the National Institutes of Health’s Draft Supplementary Risk Assessments and Site Suitability Analyses for the National Emerging Infectious Diseases Laboratory, Boston University: A Letter Report. Washington, DC: The National Academies Press. NRC (National Research Council). 2008. Technical Input on Any Additional Studies to Assess Risk Associated with Operation of the National Emerging Infectious Diseases Laboratory, Boston University: A Letter Report. Washington, DC: The National Academies Press. 10

OCR for page 10
NRC (National Research Council). 2009. Science and Decisions: Advancing Risk Assessment. Washington, DC: The National Academies Press. NRC (National Research Council). 2010a. Evaluation of the Health and Safety Risks of the New USAMRIID High- Containment Facilities at Fort Detrick, Maryland. Washington, DC: The National Academies Press. NRC (National Research Council). 2010b. Continuing Assistance to the National Institutes of Health on Preparation of Additional Risk Assessments for the Boston University NEIDL, Phase 1. Washington, DC: The National Academies Press. NRC (National Research Council). 2010c. Evaluation of a Site-Specific Risk Assessment for the Department of Homeland Security’s Planned National Bio- and Agro-Defense Facility in Manhattan, Kansas. Washington, DC: The National Academies Press. NRC (National Research Council). 2010d. Continuing Assistance to the National Institutes of Health on Preparation of Additional Risk Assessments for the Boston University NEIDL, Phase 2. Washington, DC: The National Academies Press. Rasmussen, N.C. 1981. The application of probabilistic risk assessment techniques to energy technologies. Annu. Rev. Energy 6:123-138. Reardon, S. 2011. First U.S. cowpox infection: acquired from lab contamination. Sci. Insider. February 17, 2011 [online]. Available: http://news.sciencemag.org/scienceinsider/2011/02/first-us-cowpox-infection- acquired.html [accessed April 13, 2011]. Ruben, B., J.D. Band, P. Wong, and J. Colville. 1991. Person-to-person transmission of Brucella melitensis. Lancet 337(8732):14-15. PCCRARM (Presidential/Congressional Commission on Risk Assessment and Risk Management). 1997. Framework for Environmental Health Risk Management – Final Report, Vol. 1. [online]. Available: http://www.riskworld.com/nreports/1997/risk-rpt/pdf/EPAJAN.PDF [accessed April 12, 2011]. UK-HSE (United Kingdom Health and Safety Executive). 2007. Final report On Potential Breaches of Biosecurity at the Pirbright Site 2007 [online]. Available: http://www.hse.gov.uk/news/archive/07aug/finalreport.pdf [accessed Mar. 22, 2011]. 11